Scarica l'app Stockscreener
370.33
0.33%
-1.23
Dopo l'orario di chiusura:
370.33
Precedente Chiudi:
$371.56
Aprire:
$369.77
Volume 24 ore:
261.76K
Relative Volume:
0.69
Capitalizzazione di mercato:
$41.89B
Reddito:
$5.76B
Utile/perdita netta:
$514.49M
Rapporto P/E:
82.64
EPS:
4.4813
Flusso di cassa netto:
$1.10B
1 W Prestazione:
-1.93%
1M Prestazione:
+1.20%
6M Prestazione:
+25.42%
1 anno Prestazione:
+20.15%
Intervallo 1D:
$368.49
$376.45
Intervallo di 1 settimana:
$353.89
$377.16
Portata 52W:
$253.95
$388.66
Beone Medicines Ltd Adr Stock (ONC) Company Profile
Nome
Beone Medicines Ltd Adr
Settore
Industria
Telefono
41-616851900
Indirizzo
C/O BEONE MEDICINES I GMBH, BASEL
Compare ONC vs VRTX, REGN, MRNA, ARGX
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ONC
Beone Medicines Ltd Adr
|
370.33 | 41.89B | 5.76B | 514.49M | 1.10B | 4.4813 |
VRTX
Vertex Pharmaceuticals Inc
|
558.88 | 141.65B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
927.89 | 95.53B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
221.72 | 88.52B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
892.87 | 56.15B | 4.16B | 1.29B | 734.26M | 19.58 |
Beone Medicines Ltd Adr Stock (ONC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-07-13 | Aggiornamento | Jefferies | Hold → Buy |
| 2026-03-27 | Iniziato | Wolfe Research | Outperform |
| 2026-03-16 | Downgrade | Jefferies | Buy → Hold |
| 2025-11-24 | Iniziato | Truist | Buy |
| 2025-09-18 | Iniziato | Barclays | Overweight |
| 2025-04-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-03-03 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-12-03 | Ripresa | Morgan Stanley | Overweight |
| 2024-09-18 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-02-06 | Ripresa | JP Morgan | Overweight |
| 2023-09-12 | Iniziato | Macquarie | Outperform |
| 2023-08-17 | Iniziato | Jefferies | Buy |
| 2023-07-17 | Iniziato | Citigroup | Buy |
| 2023-06-30 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-01-12 | Iniziato | Daiwa Securities | Buy |
| 2022-10-13 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-10-13 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-08-09 | Ripresa | JP Morgan | Overweight |
| 2022-03-17 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-02-07 | Iniziato | Deutsche Bank | Buy |
| 2021-10-12 | Iniziato | Bernstein | Outperform |
| 2021-10-06 | Aggiornamento | CLSA | Underperform → Buy |
| 2021-03-08 | Iniziato | China Renaissance | Buy |
| 2021-03-01 | Downgrade | CLSA | Outperform → Underperform |
| 2020-11-09 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2020-11-06 | Downgrade | Maxim Group | Buy → Hold |
| 2020-11-06 | Downgrade | Piper Sandler | Neutral → Underweight |
Mostra tutto
Beone Medicines Ltd Adr Borsa (ONC) Ultime notizie
Form 4 BeOne Medicines Ltd.: Xiaodong Wang (Director, Chair, Scientific Advisory Brd) For: 27 October - Investing.com UK
After exercising options, a BeOne Medicines (ONC) director sold 31,028 depositary shares under a trading plan. - Stock Titan
Form 4 BeOne Medicines Ltd.: Xiaodong Wang (Director, Chair, Scientific Advisory Brd) For: 13 October - Investing.com India
Form 4 BeOne Medicines Ltd.: Xiaodong Wang (Director, Chair, Scientific Advisory Brd) For: 13 October - Investing.com Nigeria
Under a preset trading plan, BeOne Medicines (ONC) director sells 31,027 depositary shares. - Stock Titan
All You Need to Know About BeOne Medicines Ltd.Sponsored ADR (ONC) Rating Upgrade to Strong Buy - Zacks Investment Research
ONC Q2 2026 Earnings: Reported EPS of 13.8375 as Shares Slip 0.2%Revenue Growth Report - dars.gov.et
ONC Q2 2026 Earnings: Reported EPS of 13.8375 as Shares Slip 0.2%Basic EPS Analysis - https://www.dars.gov.et/
Under a trading plan, BeOne Medicines (ONC) counsel sells 1,115 depositary shares at $375. - Stock Titan
Form 4 BeOne Medicines Ltd. For: 1 October By Investing.com - Investing.com Canada
Form 4 BeOne Medicines Ltd. For: 1 October By Investing.com - Investing.com Nigeria
Form 4 BeOne Medicines Ltd. For: 1 October - Investing.com India
After exercising options, BeOne Medicines (ONC) scientific advisory chair sold 31,028 depositary shares. - Stock Titan
ONC Q2 2026 Earnings: Reported EPS of $13.84 as Shares Edge LowerEarnings Volatility Report - dars.gov.et
ONC Q2 2026 Earnings: Reported EPS of $13.84 as Shares Edge LowerEPS Estimate Trend - dars.gov.et
ONC Q2 2026 Earnings: Reported EPS of $13.84 as Shares Edge LowerConsensus Beat Rate - www.dars.gov.et
BeOne Medicines (ONC) insiders exercise options for 30,768 ADS - Stock Titan
BeOne Medicines (ONC) backer Baker Bros. funds $1.1M employee ADS option exercise - Stock Titan
Engineers Gate Manager LP Acquires New Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Xiaodong Wang Sells 38,287 Shares of BeOne Medicines (NASDAQ:ONC) Stock - MarketBeat
BeOne Medicines (ONC) director trades ADS under preset plan - Stock Titan
ONC Stock Price, Quote & News - Syfe
Squarepoint Ops LLC Boosts Stock Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Baird Financial Group Inc. Raises Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Nykredit A S Invests $1.20 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Public Employees Retirement System of Ohio Invests $2.14 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
B. Metzler seel. Sohn & Co. AG Has $1.91 Million Stock Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) Insider Sells $46,973.52 in Stock - MarketBeat
BeOne Medicines (ONC) Holds Steady Near $362 Within Defined Trading RangeSmart Money Flow Stocks - careplusvn.com
BeOne Medicines (ONC) Holds Steady Near $362 Within Defined Trading RangeBPI Bear Correction - siam.in
BeOne (ONC) accounting chief sells ADS to cover RSU taxes - Stock Titan
BeOne Medicines (ONC) Holds Steady Near $362 Within Defined Trading RangeHigh Volume Node - dars.gov.et
BeOne Medicines (ONC) Holds Steady Near $362 Within Defined Trading RangeInside Day Breakout - dars.gov.et
BeOne Medicines (ONC) Holds Steady Near $362 Within Defined Trading RangeGamma Squeeze - https://www.dars.gov.et/
BeOne Medicines (NASDAQ: ONC) insider to sell 132 ADS after vesting - Stock Titan
BeOne Medicines Ltd.Sponsored ADR (ONC) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
BeOne Medicines COO Wu Xiaobin Executes ADS Sale Under Rule 10b5-1 Trading Plan - Kalkine Media
BeOne Medicines Ltd.Sponsored ADR (ONC) Now Trades Above Golden Cross: Time to Buy? - Yahoo Finance
BeOne Medicines (NASDAQ: ONC) ex-director lines up $788K ADS sale - Stock Titan
BeOne (ONC) Earnings Snapshot: Available Data Shows the Latest Reported Performance for This Review; Trading Response: The Share Price Adds 1.44% in Latest TradingEPS Surprise History - dars.gov.et
BeOne Medicines stock rises nearly 4% as buyers control session amid bullish technicals - Traders Union
BeOne Medicines (ONC) Secures Rights To Four RAS(ON) Inhibitors In Asia - Sahm
BeOne Medicines (NASDAQ:ONC) SVP Sells 2,666 Shares of Stock - MarketBeat
Insider Selling: BeOne Medicines (NASDAQ:ONC) CEO Sells $25,661,243.30 in Stock - MarketBeat
BeOne Medicines (NASDAQ:ONC) CEO Sells $19,659,569.80 in Stock - MarketBeat
BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Generali Investments Management Co LLC Buys Shares of 8,000 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
The Manufacturers Life Insurance Company Trims Stake in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Charles Schwab Trust Co Acquires New Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Beone Medicines Ltd Adr Azioni (ONC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Beone Medicines Ltd Adr Azioni (ONC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Wang Xiaodong | Chair, Scientific Advisory Brd |
Oct 27 '26 |
Sale |
362.97 |
31,028 |
11,262,131 |
0 |
| Wang Xiaodong | Chair, Scientific Advisory Brd |
Oct 13 '26 |
Sale |
350.99 |
31,027 |
10,890,074 |
0 |
| Wang Xiaodong | Chair, Scientific Advisory Brd |
Oct 13 '26 |
Option Exercise |
36.90 |
31,027 |
1,144,896 |
31,027 |
| CHAN LEE | Officer |
Sep 30 '26 |
Proposed Sale |
365.27 |
1,115 |
407,276 |
0 |
| Lee Chan Henry | SVP, General Counsel |
Sep 30 '26 |
Sale |
375.00 |
1,115 |
418,125 |
0 |
| Wang Xiaodong | Chair, Scientific Advisory Brd |
Sep 28 '26 |
Option Exercise |
36.90 |
31,028 |
1,144,933 |
31,028 |
| Wang Xiaodong | Chair, Scientific Advisory Brd |
Sep 28 '26 |
Sale |
364.79 |
31,028 |
11,318,558 |
0 |
| Wang Xiaodong | Chair, Scientific Advisory Brd |
Sep 08 '26 |
Sale |
349.10 |
38,287 |
13,366,092 |
0 |
| XIAODONG WANG | Director |
Sep 08 '26 |
Proposed Sale |
358.26 |
131,370 |
47,064,616 |
0 |
| Wang Xiaodong | Chair, Scientific Advisory Brd |
Sep 08 '26 |
Option Exercise |
36.90 |
31,027 |
1,144,896 |
31,027 |
0.55%
0.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):